Patent ID: 9637489
Date: 2017-05-02
CPC Classifications: A61K,A61P,C07D,Y02A

Claim:
1. A method of treating a condition selected from the group consisting of an autoimmune disease, inflammation, allergy, asthma, graft rejection, graft-versus host disease (GvHD), and sepsis, in a mammalian species in need thereof, comprising administering to the mammalian species a therapeutically effective amount of at least one compound of Formula I or a pharmaceutically acceptable salt thereof, wherein X is absent or is an optionally substituted alkyl, cycloalkyl, aryl, alkylaryl, or heterocycle; Q is H, (CH R R R Y is oxygen, sulfur, or NR R L is alkyl or alkenyl containing from 2 to 10 carbon atoms; R R each occurrence of p is independently 2-4; each occurrence of R each occurrence of R provided that when R wherein the autoimmune disease and inflammation are each characterized by unwanted immune activity.